Larimar Therapeutics, Inc. (LRMR)
4.10
+0.13
(+3.27%)
USD |
NASDAQ |
May 11, 11:27
Larimar Therapeutics Market Cap : 425.92M for May 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vir Biotechnology, Inc. | 1.624B |
| Gossamer Bio, Inc. | 77.87M |
| ImmunityBio, Inc. | 8.829B |
| Biogen, Inc. | 29.54B |
| BioRestorative Therapies, Inc. | 5.220M |
Market Cap Related Metrics
| PEG Ratio | -0.0270 |
| Price to Book Value | 5.455 |
| Price | 4.10 |
| Earnings Yield | -53.84% |
| PEGY Ratio | -0.0270 |